Your browser doesn't support javascript.
loading
The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study.
Livingston, Nicholas A; Davenport, Michael; Head, Michael; Henke, Rachel; LeBeau, Lavonia Smith; Gibson, Teresa B; Banducci, Anne N; Sarpong, Alexis; Jayanthi, Saketh; Roth, Clara; Camacho-Cook, Jessica; Meng, Frank; Hyde, Justeen; Mulvaney-Day, Norah; White, Mackenzie; Chen, Daniel C; Stein, Michael D; Weisberg, Risa.
Affiliation
  • Livingston NA; National Center for PTSD, Behavioral Sciences Division, VA Boston Healthcare System, Boston, MA, USA; US Department of Veterans Affairs, VA Boston Healthcare System, Boston, MA, USA; Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA. Electronic address: nicholas.livings
  • Davenport M; Data Science Core, Boston CSPCC, VA Boston Healthcare System, Boston, MA, USA.
  • Head M; IBM Consulting, Cambridge, MA, USA.
  • Henke R; IBM Consulting, Cambridge, MA, USA.
  • LeBeau LS; IBM Consulting, Cambridge, MA, USA.
  • Gibson TB; IBM Consulting, Cambridge, MA, USA.
  • Banducci AN; US Department of Veterans Affairs, VA Boston Healthcare System, Boston, MA, USA; Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA; National Center for PTSD, Women's Health Sciences Division, VA Boston Healthcare System, Boston, MA, USA.
  • Sarpong A; Boston VA Research Institute, Boston, MA, USA.
  • Jayanthi S; Boston VA Research Institute, Boston, MA, USA.
  • Roth C; Boston VA Research Institute, Boston, MA, USA.
  • Camacho-Cook J; IBM Consulting, Cambridge, MA, USA.
  • Meng F; Data Science Core, Boston CSPCC, VA Boston Healthcare System, Boston, MA, USA; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
  • Hyde J; Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System, US Department of Veterans Affairs, Bedford, MA, USA; General Internal Medicine, Boston University School of Medicine, Boston, MA, USA.
  • Mulvaney-Day N; Department of Psychiatry, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, USA.
  • White M; IBM Consulting, Cambridge, MA, USA.
  • Chen DC; Data Science Core, Boston CSPCC, VA Boston Healthcare System, Boston, MA, USA; General Internal Medicine, Boston University School of Medicine, Boston, MA, USA.
  • Stein MD; Health Law, Policy & Management, Boston University School of Public Health, MA, USA.
  • Weisberg R; US Department of Veterans Affairs, VA Boston Healthcare System, Boston, MA, USA; Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA; Department of Family Medicine, Alpert Medical School of Brown University, Providence, RI, USA; BehaVR, Inc, Elizabethtown, KY, USA.
Drug Alcohol Depend ; 241: 109678, 2022 Dec 01.
Article in En | MEDLINE | ID: mdl-36368167

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / COVID-19 / Opioid-Related Disorders Type of study: Etiology_studies / Observational_studies Limits: Humans Language: En Journal: Drug Alcohol Depend Year: 2022 Document type: Article Country of publication: Ireland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / COVID-19 / Opioid-Related Disorders Type of study: Etiology_studies / Observational_studies Limits: Humans Language: En Journal: Drug Alcohol Depend Year: 2022 Document type: Article Country of publication: Ireland